HBAN vs PCSA · P/E 13, rev $1.56B vs $5.9M cap
Huntington Bancshares Incorporated (HBAN) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
PCSA does not have a complete income-statement cache yet.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the HBAN and PCSA stock pages for the full models.
Not investment advice.